We're making updates and relaunching soon. Get notified

Straight answers about GLP-1 medications

Plain-language guides on dosing, side effects, costs, and what to look for in a provider.

Relaunching Soon

  • Relaunching as an independent GLP-1 guide
  • Get notified when we relaunch
  • We only ask for your email
Get Started

One email to confirm. Unsubscribe anytime.

Compounded Oral Semaglutide: How It Works and Cost

Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality. Compounded oral semaglutide is not the same as brand-name products such as Rybelsus or Wegovy tablets and may differ in formulation, purity, and potency.

You have decided semaglutide makes sense for your situation, but the idea of a weekly injection is holding you back. The good news is that semaglutide also comes in a daily oral form, and some telehealth programs offer a compounded version of it.

This page covers what compounded oral semaglutide is, how it differs from the brand-name tablets and the injection, who tends to prefer it, and how the prescription process usually works at telehealth programs if a provider decides it is appropriate for you.

What compounded oral semaglutide is

Compounded oral semaglutide is a daily oral formulation that includes semaglutide. It is prepared differently from injectable compounded semaglutide, it is not the same thing, and it has different instructions for use. Instead of a weekly shot, it is usually taken once a day; how and when to take it depends on the formulation, so follow the prescriber’s and pharmacy’s instructions. It is an option for people who would rather avoid needles altogether.

“Compounded” means the medication is prepared by a state-licensed compounding pharmacy rather than manufactured by the drug’s maker under an FDA-approved application. That carries an important distinction: compounded semaglutide is not an FDA-approved product. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed[1], and compounded semaglutide is not the same as brand-name semaglutide products. We cover that distinction in the disclosures at the end of this page, and it is something to discuss with the provider you choose.

Oral semaglutide is not only available through compounding. The FDA has approved semaglutide tablets: Rybelsus, for adults with type 2 diabetes[2], and Wegovy tablets, for long-term weight management in adults with obesity, or with overweight and at least one weight-related condition[3]. Compounded oral semaglutide is not the same as these products.

At most telehealth programs, a licensed provider reviews your health history and decides whether a prescription is appropriate. Transformation Health does not prescribe or sell medication.

How oral semaglutide differs from the injection

Both forms contain semaglutide, but they are taken very differently, and that is usually what decides which one fits a person’s life.

The clearest difference is frequency. Oral semaglutide is taken every day. Injectable semaglutide is taken once a week. A daily routine works well for some people and feels like a burden to others.

The second difference is absorption. Because the oral form is swallowed, it has to make it through your digestive system, which is harder than delivering medication under the skin. The FDA-approved tablets contain an absorption enhancer (salcaprozate sodium, or SNAC), and the Rybelsus label still estimates that only about 0.4% to 1% of each dose reaches the bloodstream (its absolute bioavailability)[2]. That is why the label instructions are strict: take the tablet on an empty stomach in the morning with no more than 4 ounces of plain water, then wait at least 30 minutes before eating, drinking, or taking other oral medications[2][3]. The injection bypasses your digestive system, so its absorption does not depend on those daily habits.

Compounded oral formulations are not required to use the same ingredients or design as the FDA-approved tablets, and the FDA has not evaluated whether any compounded oral product delivers semaglutide as intended. Ask the provider what form the medication comes in, what it contains, and exactly how to take it.

Neither form is automatically “better.” The right choice depends on whether you would rather avoid a needle or avoid a daily routine. For a complete side-by-side look at dosing, absorption, side effects, and travel, see our oral semaglutide vs injection guide.

Who might prefer the oral option

Some people have a clear reason to choose the pill, and it is worth being honest about whether you are one of them.

You might prefer oral semaglutide if you have genuine needle anxiety or simply do not want to give yourself a weekly injection. That is a legitimate factor in a medical decision, not a weakness, and it is a common reason people look for an oral option in the first place.

You might also prefer it if you already have a steady daily rhythm. If you wake up at a similar time most days and already take a morning vitamin or medication, building a once-a-day tablet into that routine can feel natural. The daily form rewards consistency, so a predictable schedule helps.

On the other hand, if your mornings are unpredictable or you travel constantly, the once-weekly injection may actually be simpler. A licensed provider can help you weigh these tradeoffs against your health history before anything is prescribed.

Does oral semaglutide work

This is the question most people want answered, and the honest version has two parts.

The active ingredient, semaglutide, has been studied in clinical trials for weight management, and the FDA approved Wegovy tablets for long-term weight management based on trials of that product[3]. Semaglutide works by acting on appetite signals in the brain and gut, which can help reduce appetite as part of a broader plan that includes nutrition and activity.

Here is the part that matters for any compounded option. Compounded oral semaglutide has not been evaluated by the FDA, and the published trials studied brand-name formulations, not compounded ones. So while the active ingredient is well studied, you should not assume a compounded version will behave the same way. The FDA has also warned that some compounders may use salt forms of semaglutide (such as semaglutide sodium or semaglutide acetate), which are different active ingredients from the one in the approved drugs[1]. Ask the provider which form of semaglutide the pharmacy uses.

Semaglutide has risks as well as benefits. On the FDA label for brand-name semaglutide (Wegovy injection and tablets), the most common side effects include nausea, diarrhea, vomiting, constipation, and abdominal pain, and the label carries a boxed warning about thyroid C-cell tumors[3]. Label information describes the brand-name product studied, not compounded versions.

Individual results vary, and weight loss is not guaranteed. Semaglutide is a tool, not a cure. Many programs pair the medication with nutrition guidance and follow-up visits; ask what the program you are considering includes. A licensed provider can help you understand what a realistic outcome looks like for your situation.

What it costs and how to get it

Prices vary by program and dose. Transformation Health does not sell medication or set prices. We plan to publish current market prices with sources and capture dates; until then, compare what programs quote you on the total cost:

  • Medication at your likely dose. A starting-dose price may not be the price you pay later.
  • Dose increases. Ask whether the price changes as the dose goes up.
  • Provider visits and labs. Some programs include them; others bill them separately.
  • Shipping. Check whether it is included.
  • Membership fees and cancellation terms. Look for separate fees, minimum commitments, prepay requirements, and how cancellation works.

Transformation Health does not accept payment from providers. How we make money.

Getting a prescription is not the same as buying a medication off a shelf. A licensed provider decides whether a prescription is appropriate for you. Here is how the process usually works at telehealth programs:

Step 1: Health history

At most telehealth programs, you fill out an online form covering your health history, current medications, and goals.

Step 2: Provider review

A licensed provider reviews your information and decides whether compounded oral semaglutide is clinically appropriate. A provider may decide it is not.

Step 3: Pharmacy preparation

If a provider prescribes it, a state-licensed compounding pharmacy prepares the medication. Ask which pharmacy the program uses.

Step 4: Delivery and follow-up

The medication usually arrives by mail. A proper program includes follow-up with a licensed provider while you take it.

For a deeper walkthrough of the prescription process, see our guide on how to get compounded semaglutide, or see what drives the price on the compounded semaglutide cost page.

Eligibility

A licensed provider decides whether any GLP-1 medication is appropriate based on your health history. Programs set their own criteria.

Many programs use body mass index (BMI) thresholds similar to those in the semaglutide weight-management trials. The STEP 1 trial, for example, enrolled adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition[4]. These are starting points, not guarantees. Even if your BMI meets a program’s threshold, a provider may decide semaglutide is not right for your health situation.

Visit requirements, such as whether a live video visit is needed before a prescription, can depend on the program and on state rules. Ask the program what applies where you live. You can read more in our GLP-1 eligibility guide, and you can review all compounded options on the compounded medications overview.

We're relaunching soon

We're relaunching as an independent GLP-1 guide. Leave your email and we'll let you know when your free custom report is ready.

Get Started

Important disclosures

This content is for general education and is not medical advice. Talk with a licensed provider about your situation.

Compounded oral semaglutide is not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed[1]. Compounded semaglutide is not the same as brand-name products such as Rybelsus or Wegovy and may differ in formulation, purity, and potency. A prescription is required, and a licensed provider decides whether one is appropriate.

Regulatory status is subject to change. The FDA determined that the tirzepatide injection shortage was resolved on December 19, 2024, and that the semaglutide injection shortage was resolved on February 21, 2025. The FDA has posted later updates to its compounding policy, most recently dated April 1, 2026; check the FDA page for the current statement[5]. Compounding of semaglutide depends on federal and state pharmacy law and on FDA policy, and availability cannot be guaranteed.

Results vary. Weight loss is not guaranteed. Trial results describe study participants and are not a prediction for any individual.

Citations

[1] U.S. Food and Drug Administration. “FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss.” Content current as of 10/01/2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss (Accessed 2026-10-16. Supports: FDA does not review compounded drugs; salt-form warning.)

[2] U.S. Food and Drug Administration. RYBELSUS (semaglutide) tablets, prescribing information, sections 1, 2.1, and 12.3. Revised 1/2026. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/213051Orig1s030lbl.pdf (Supports: indication, administration instructions, SNAC, estimated absolute bioavailability.)

[3] U.S. Food and Drug Administration. WEGOVY (semaglutide) injection and tablets, prescribing information, Boxed Warning and sections 1, 2, and 6. Revised 06/2026. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215256s025lbl.pdf (Supports: tablet indication and administration, common side effects, boxed warning.)

[4] Wilding JPH, Batterham RL, Calanna S, et al. “Once-Weekly Semaglutide in Adults with Overweight or Obesity.” N Engl J Med. 2021. https://pubmed.ncbi.nlm.nih.gov/33567185/ (Supports: STEP 1 BMI inclusion criteria.)

[5] U.S. Food and Drug Administration. “FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize.” Content current as of 04/01/2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize (Accessed 2026-10-16. Supports: shortage resolution dates.)

Important: This content is for general education and is not medical advice. Talk with a licensed provider about your situation. Transformation Health is an independent GLP-1 guide. It does not provide medical care, prescribe, compound, or sell medication. A licensed provider decides whether a prescription is appropriate. Compounded semaglutide is not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, or quality. Compounded semaglutide is not the same as brand-name products such as Rybelsus or Wegovy and may differ in formulation, purity, and potency. Results vary. Trial results describe study participants and are not a prediction for any individual. Availability of compounded semaglutide depends on FDA policy and applicable state and federal pharmacy compounding laws, which may change. Rybelsus and Wegovy are trademarks of Novo Nordisk A/S. Transformation Health is not affiliated with or endorsed by Novo Nordisk. Transformation Health does not accept payment from providers. How we make money.

FAQ

Frequently Asked Questions

Everything you need to know about getting started.

Still have questions?

Contact our support team
Is there an oral version of semaglutide?
Yes. Semaglutide comes as a weekly injection and as a daily tablet. FDA-approved semaglutide tablets include Rybelsus (for type 2 diabetes) and Wegovy tablets (for chronic weight management). Some telehealth programs also offer compounded oral semaglutide, which is not FDA-approved and is not the same as those products. A licensed provider decides whether any of these is appropriate for you.
How does oral semaglutide compare to the injection?
The main practical differences are how often you take it and how it is absorbed. Oral semaglutide is taken every day, while injectable semaglutide is taken once a week. The FDA-approved tablets must be taken on an empty stomach with a small amount of water, followed by a wait before eating or drinking. Compounded oral formulations vary, so ask the provider how the one you are prescribed should be taken. Our oral semaglutide vs injection guide covers the differences in detail.
How much does compounded oral semaglutide cost?
Prices vary by program and dose. Some programs bundle medication, provider visits, and labs into one monthly fee; others bill them separately or charge more as the dose increases. Compare the total cost, including medication at your likely dose, dose increases, provider visits, labs, shipping, membership fees, and cancellation terms.
Who is oral semaglutide a good fit for?
Oral semaglutide tends to suit people who want to avoid injections and who have a stable daily routine they can build a once-a-day medication around. It is not the right fit for everyone. A licensed provider can weigh your preferences, health history, and lifestyle and decide which option, if any, is appropriate.
Is compounded oral semaglutide FDA-approved?
No. Compounded oral semaglutide is not FDA-approved. It is prepared by a compounding pharmacy, and the FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. It is not the same as FDA-approved semaglutide tablets. A licensed provider decides whether a prescription is appropriate.

We're relaunching soon

We're relaunching as an independent GLP-1 guide. Leave your email and we'll let you know when your free custom report is ready.

Get Started

About This Site: Disclosures

Who We Are

transformationhealth.com is a website operated by Amerigo Health LLC. Transformation Health is an independent publisher. It does not provide medical care, prescribe, or sell medication, and does not give medical advice. Providers and programs mentioned on this site are independent third parties.

How We Make Money

Transformation Health does not accept payment from providers.

Educational Purpose

This content is for general education and is not medical advice. Talk with a licensed provider about your situation. Results vary. Trial results describe study participants and are not a prediction for any individual.

Compounded Medications

Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality. Compounded semaglutide and tirzepatide are not the same as brand-name products such as Wegovy, Ozempic, Zepbound, or Mounjaro. They may differ in formulation, purity, and potency.

Trademarks

Wegovy and Ozempic are trademarks of Novo Nordisk A/S. Zepbound and Mounjaro are trademarks of Eli Lilly and Company. Transformation Health is not affiliated with or endorsed by these companies.